1-161826106-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_007348.4(ATF6):​c.1187+4945G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.153 in 152,082 control chromosomes in the GnomAD database, including 2,715 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 2715 hom., cov: 32)

Consequence

ATF6
NM_007348.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.354

Publications

3 publications found
Variant links:
Genes affected
ATF6 (HGNC:791): (activating transcription factor 6) This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]
ATF6 Gene-Disease associations (from GenCC):
  • achromatopsia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • ATF6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • achromatopsia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.319 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007348.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATF6
NM_007348.4
MANE Select
c.1187+4945G>A
intron
N/ANP_031374.2
ATF6
NM_001437597.1
c.1187+4945G>A
intron
N/ANP_001424526.1
ATF6
NM_001410890.1
c.1187+4945G>A
intron
N/ANP_001397819.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATF6
ENST00000367942.4
TSL:1 MANE Select
c.1187+4945G>A
intron
N/AENSP00000356919.3
ATF6
ENST00000681492.1
c.1187+4945G>A
intron
N/AENSP00000506139.1
ATF6
ENST00000680688.1
c.1187+4945G>A
intron
N/AENSP00000504865.1

Frequencies

GnomAD3 genomes
AF:
0.152
AC:
23149
AN:
151964
Hom.:
2699
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.323
Gnomad AMI
AF:
0.0462
Gnomad AMR
AF:
0.0711
Gnomad ASJ
AF:
0.0384
Gnomad EAS
AF:
0.205
Gnomad SAS
AF:
0.0515
Gnomad FIN
AF:
0.0838
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0896
Gnomad OTH
AF:
0.112
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.153
AC:
23195
AN:
152082
Hom.:
2715
Cov.:
32
AF XY:
0.148
AC XY:
10989
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.323
AC:
13401
AN:
41442
American (AMR)
AF:
0.0710
AC:
1085
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0384
AC:
133
AN:
3468
East Asian (EAS)
AF:
0.204
AC:
1058
AN:
5178
South Asian (SAS)
AF:
0.0511
AC:
247
AN:
4830
European-Finnish (FIN)
AF:
0.0838
AC:
885
AN:
10556
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0896
AC:
6095
AN:
68000
Other (OTH)
AF:
0.112
AC:
237
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
892
1783
2675
3566
4458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.101
Hom.:
4413
Bravo
AF:
0.159
Asia WGS
AF:
0.118
AC:
412
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
12
DANN
Benign
0.90
PhyloP100
-0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10918029; hg19: chr1-161795896; API